Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

28.00
-0.0500-0.18%
Post-market: 28.000.00000.00%19:06 EDT
Volume:1.31M
Turnover:36.69M
Market Cap:1.67B
PE:-3.93
High:28.68
Open:28.07
Low:27.71
Close:28.05
52wk High:46.00
52wk Low:22.24
Shares:59.47M
Float Shares:50.62M
Volume Ratio:0.97
T/O Rate:2.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1203
EPS(LYR):-7.1203
ROE:-30.20%
ROA:-19.94%
PB:1.40
PE(LYR):-3.93

Loading ...

RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO)

TIPRANKS
·
2 hours ago

Agios Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Yesterday

Agios publishes 2025 annual report

Reuters
·
Yesterday

Agios Pharmaceuticals announces annual shareholder meeting webcast details

Reuters
·
Yesterday

Stock Track | Agios Pharmaceuticals Soars 9.68% Intraday on Strong Q1 Revenue Beat and Successful Drug Launch

Stock Track
·
Apr 29

Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat

Stock Track
·
Apr 29

Agios Q1 FY26 net loss widens to $99.1 million; net product revenue rises to $18.8 million

Reuters
·
Apr 29

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss

MT Newswires Live
·
Apr 29

Biopharma firm Agios Q1 product revenue more than doubles, beats estimates

Reuters
·
Apr 29

Agios Pharmaceuticals Q1 EPS $(1.69) Beats $(1.79) Estimate, Sales $20.746M Beat $13.646M Estimate

Benzinga
·
Apr 29

BRIEF-Agios Pharmaceuticals Q1 Product Revenue USD 20.746 Million Vs. IBES Estimate USD 13.6 Million

Reuters
·
Apr 29

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Apr 29

Agios Pharmaceuticals Q1 Net Income USD -99.111 Million

THOMSON REUTERS
·
Apr 29

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 29

Agios Pharmaceuticals announces annual shareholder meeting notice

Reuters
·
Apr 25

Agios Pharmaceuticals price target lowered to $41 from $44 at BofA

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO) and Palvella Therapeutics (PVLA)

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), GeneDx Holdings (WGS) and Agios Pharma (AGIO)

TIPRANKS
·
Apr 21

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Reuters
·
Apr 21

Agios Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 21